Comprehensive mapping and analysis of Kaposi's sarcoma-associated herpesvirus 3' UTRs identify differential posttranscriptional control of gene expression in lytic versus latent infection

Journal of Virology

Volumn 87, Issue 23, 2013, Pages 12838-12849

  McClure, Lydia V ^a   Kincaid, Rodney P ^a   Burke, James M ^a   Grundhoff, Adam ^b   Sullivan, Christopher S ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b LEIBNIZ INSTITUTE FOR EXPERIMENTAL VIROLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

3' UNTRANSLATED REGION; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE AMPLIFICATION; GENE CONTROL; GENE EXPRESSION; GENE MAPPING; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; INFECTION; LATENT VIRUS INFECTION; LYTIC VIRUS INFECTION; MICROARRAY ANALYSIS; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY RNA SEQUENCE; RNA SEQUENCE;

3' UNTRANSLATED REGIONS; CELL LINE; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 8, HUMAN; HUMANS; PROMOTER REGIONS, GENETIC; VIRAL PROTEINS; VIRUS LATENCY; VIRUS REPLICATION;

EID: 84887189506     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02374-13     Document Type: Article

References (85)

1. Elkon R, Ugalde AP, Agami R. 2013. Alternative cleavage and polyadenylation: extent, regulation and function. Nat. Rev. Genet. 14:496-506.
2. Calin GA, Liu CG, Sevignani C, Ferracin M, Felli N, Dumitru CD, Shimizu M, Cimmino A, Zupo S, Dono M, Dell'Aquila ML, Alder H, Rassenti L, Kipps TJ, Bullrich F, Negrini M, Croce CM. 2004. MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc. Natl. Acad. Sci. U.S.A. 101:11755-11760.
3. Lin YT, Sullivan CS. 2011. Expanding the role of Drosha to the regulation of viral gene expression. Proc. Natl. Acad. Sci. U.S.A. 108:11229-11234.
4. Shaw G, Kamen R. 1986. A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 46:659-667.
5. Zhang Y, Xie RL, Croce CM, Stein JL, Lian JB, van Wijnen AJ, Stein GS. 2011. A program of microRNAs controls osteogenic lineage progression by targeting transcription factor Runx2. Proc. Natl. Acad. Sci. U.S.A. 108:9863-9868.
6. Jan CH, Friedman RC, Ruby JG, Bartel DP. 2011. Formation, regulation and evolution of Caenorhabditis elegans 3'UTRs. Nature 469:97-101.
7. Mangone M, Manoharan AP, Thierry-Mieg D, Thierry-Mieg J, Han T, Mackowiak SD, Mis E, Zegar C, Gutwein MR, Khivansara V, Attie O, Chen K, Salehi-Ashtiani K, Vidal M, Harkins TT, Bouffard P, Suzuki Y, Sugano S, Kohara Y, Rajewsky N, Piano F, Gunsalus KC, Kim JK. 2010. The landscape of C. elegans 3'UTRs. Science 329:432-435.
8. Pineiro D, Martinez-Salas E. 2012. RNA structural elements of hepatitis C virus controlling viral RNA translation and the implications for viral pathogenesis. Viruses 4:2233-2250.
9. Ganem D. 2007. Kaposi's sarcoma-associated herpesvirus, p 2847-2888. In Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (ed), Fields virology, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
10. Russo JJ, Bohenzky RA, Chien MC, Chen J, Yan M, Maddalena D, Parry JP, Peruzzi D, Edelman IS, Chang Y, Moore PS. 1996. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc. Natl. Acad. Sci. U.S.A. 93:14862-14867.
11. Chang HH, Ganem D. 2013. A unique herpesviral transcriptional program in KSHV-infected lymphatic endothelial cells leads to mTORC1 activation and rapamycin sensitivity. Cell Host Microbe 13:429-440.
12. Chandriani S, Xu Y, Ganem D. 2010. The lytic transcriptome of Kaposi's sarcoma-associated herpesvirus reveals extensive transcription of noncoding regions, including regions antisense to important genes. J. Virol. 84:7934-7942.
13. Gradoville L, Gerlach J, Grogan E, Shedd D, Nikiforow S, Metroka C, Miller G. 2000. Kaposi's sarcoma-associated herpesvirus open reading frame 50/Rta protein activates the entire viral lytic cycle in the HH-B2 primary effusion lymphoma cell line. J. Virol. 74:6207-6212.
14. Mesri EA, Cesarman E, Boshoff C. 2010. Kaposi's sarcoma and its associated herpesvirus. Nat. Rev. Cancer 10:707-719.
15. Arias C, Walsh D, Harbell J, Wilson AC, Mohr I. 2009. Activation of host translational control pathways by a viral developmental switch. PLoS Pathog. 5:e1000334. doi:10.1371/journal.ppat.1000334.
16. Nakamura H, Lu M, Gwack Y, Souvlis J, Zeichner SL, Jung JU. 2003. Global changes in Kaposi's sarcoma-associated virus gene expression patterns following expression of a tetracycline-inducible Rta transactivator. J. Virol. 77:4205-4220.
17. Weber K, Bolander ME, Sarkar G. 1998. PIG-B:a homemade monophasic cocktail for the extraction of RNA. Mol. Biotechnol. 9:73-77.
18. Chen CJ, Kincaid RP, Seo GJ, Bennett MD, Sullivan CS. 2011. Insights into Polyomaviridae microRNA function derived from study of the bandicoot papillomatosis carcinomatosis viruses. J. Virol. 85:4487-4500.
19. Gunther T, Grundhoff A. 2010. The epigenetic landscape of latent Kaposi sarcoma-associated herpesvirus genomes. PLoS Pathog. 6:e1000935. doi: 10.1371/journal.ppat.1000935.
20. Sonenberg N, Hinnebusch AG. 2009. Regulation of translation initiation in eukaryotes:mechanisms and biological targets. Cell 136:731-745.
21. Cheng Y, Miura RM, Tian B. 2006. Prediction of mRNA polyadenylation sites by support vector machine. Bioinformatics 22:2320-2325.
22. Chiou HC, Dabrowski C, Alwine JC. 1991. Simian virus 40 late mRNA leader sequences involved in augmenting mRNA accumulation via multiple mechanisms, including increased polyadenylation efficiency. J. Virol. 65:6677-6685.
23. Lin SF, Robinson DR, Miller G, Kung HJ. 1999. Kaposi's sarcomaassociated herpesvirus encodes a bZIP protein with homology to BZLF1 of Epstein-Barr virus. J. Virol. 73:1909-1917.
24. Lukac DM, Kirshner JR, Ganem D. 1999. Transcriptional activation by the product of open reading frame 50 of Kaposi's sarcoma-associated herpesvirus is required for lytic viral reactivation in B cells. J. Virol. 73:9348-9361.
25. Majerciak V, Yamanegi K, Zheng ZM. 2006. Gene structure and expression of Kaposi's sarcoma-associated herpesvirus ORF56, ORF57, ORF58, and ORF59. J. Virol. 80:11968-11981.
26. Polson AG, Huang L, Lukac DM, Blethrow JD, Morgan DO, Burlingame AL, Ganem D. 2001. Kaposi's sarcoma-associated herpesvirus KbZIP protein is phosphorylated by cyclin-dependent kinases. J. Virol. 75: 3175-3184.
27. Legendre M, Gautheret D. 2003. Sequence determinants in human polyadenylation site selection. BMC Genomics 4:7. doi:10.1186/1471-2164-4-7.
28. Edwalds-Gilbert G, Veraldi KL, Milcarek C. 1997. Alternative poly(A) site selection in complex transcription units:means to an end? Nucleic Acids Res. 25:2547-2561.
29. Tian B, Hu J, Zhang H, Lutz CS. 2005. A large-scale analysis of mRNA polyadenylation of human and mouse genes. Nucleic Acids Res. 33:201-212.
30. Colgan DF, Manley JL. 1997. Mechanism and regulation of mRNA polyadenylation. Genes Dev. 11:2755-2766.
31. Beaudoing E, Freier S, Wyatt JR, Claverie JM, Gautheret D. 2000. Patterns of variant polyadenylation signal usage in human genes. Genome Res. 10:1001-1010.
32. Bello LJ, Davison AJ, Glenn MA, Whitehouse A, Rethmeier N, Schulz TF, Barklie Clements J. 1999. The human herpesvirus-8 ORF 57 gene and its properties. J. Gen. Virol. 80(Part 12):3207-3215.
33. Bieleski L, Hindley C, Talbot SJ. 2004. A polypyrimidine tract facilitates the expression of Kaposi's sarcoma-associated herpesvirus vFLIP through an internal ribosome entry site. J. Gen. Virol. 85:615-620.
34. Bisson SA, Page AL, Ganem D. 2009. A Kaposi's sarcoma-associated herpesvirus protein that forms inhibitory complexes with type I interferon receptor subunits, Jak and STAT proteins, and blocks interferonmediated signal transduction. J. Virol. 83:5056-5066.
35. Chen L, Park MS. 2009. Identification and characterization of the promoter region of Kaposi's sarcoma-associated herpesvirus ORF11. Virus Res. 142:160-168.
36. Chiou CJ, Poole LJ, Kim PS, Ciufo DM, Cannon JS, ap Rhys CM, Alcendor DJ, Zong JC, Ambinder RF, Hayward GS. 2002. Patterns of gene expression and a transactivation function exhibited by the vGCR (ORF74) chemokine receptor protein of Kaposi's sarcoma-associated herpesvirus. J. Virol. 76:3421-3439.
37. Cunningham C, Barnard S, Blackbourn DJ, Davison AJ. 2003. Transcription mapping of human herpesvirus 8 genes encoding viral interferon regulatory factors. J. Gen. Virol. 84:1471-1483.
38. Deng H, Song MJ, Chu JT, Sun R. 2002. Transcriptional regulation of the interleukin-6 gene of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus). J. Virol. 76:8252-8264.
39. Dittmer D, Lagunoff M, Renne R, Staskus K, Haase A, Ganem D. 1998. A cluster of latently expressed genes in Kaposi's sarcoma-associated herpesvirus. J. Virol. 72:8309-8315.
40. Gonzalez CM, Wong EL, Bowser BS, Hong GK, Kenney S, Damania B. 2006. Identification and characterization of the Orf49 protein of Kaposi's sarcoma-associated herpesvirus. J. Virol. 80:3062-3070.
41. Grundhoff A, Ganem D. 2001. Mechanisms governing expression of the v-FLIP gene of Kaposi's sarcoma-associated herpesvirus. J. Virol. 75: 1857-1863.
42. Haque M, Chen J, Ueda K, Mori Y, Nakano K, Hirata Y, Kanamori S, Uchiyama Y, Inagi R, Okuno T, Yamanishi K. 2000. Identification and analysis of the K5 gene of Kaposi's sarcoma-associated herpesvirus. J. Virol. 74:2867-2875.
43. Haque M, Wang V, Davis DA, Zheng ZM, Yarchoan R. 2006. Genetic organization and hypoxic activation of the Kaposi's sarcoma-associated herpesvirus ORF34-37 gene cluster. J. Virol. 80:7037-7051.
44. Krishnan HH, Naranatt PP, Smith MS, Zeng L, Bloomer C, Chandran B. 2004. Concurrent expression of latent and a limited number of lytic genes with immune modulation and antiapoptotic function by Kaposi's sarcoma-associated herpesvirus early during infection of primary endothelial and fibroblast cells and subsequent decline of lytic gene expression. J. Virol. 78:3601-3620.
45. Lin HR, Ganem D. 2011. Viral microRNA target allows insight into the role of translation in governing microRNA target accessibility. Proc. Natl. Acad. Sci. U.S.A. 108:5148-5153.
46. Lin SF, Sun R, Heston L, Gradoville L, Shedd D, Haglund K, Rigsby M, Miller G. 1997. Identification, expression, and immunogenicity of Kaposi's sarcoma-associated herpesvirus-encoded small viral capsid antigen. J. Virol. 71:3069-3076.
47. Masa SR, Lando R, Sarid R. 2008. Transcriptional regulation of the open reading frame 35 encoded by Kaposi's sarcoma-associated herpesvirus. Virology 371:14-31.
48. Murphy E, Vanicek J, Robins H, Shenk T, Levine AJ. 2008. Suppression of immediate-early viral gene expression by herpesvirus-coded microRNAs:implications for latency. Proc. Natl. Acad. Sci. U.S.A. 105:5453-5458.
49. Nador RG, Milligan LL, Flore O, Wang X, Arvanitakis L, Knowles DM, Cesarman E. 2001. Expression of Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor monocistronic and bicistronic transcripts in primary effusion lymphomas. Virology 287:62-70.
50. Rimessi P, Bonaccorsi A, Sturzl M, Fabris M, Brocca-Cofano E, Caputo A, Melucci-Vigo G, Falchi M, Cafaro A, Cassai E, Ensoli B, Monini P. 2001. Transcription pattern of human herpesvirus 8 open reading frame K3 in primary effusion lymphoma and Kaposi's sarcoma. J. Virol. 75: 7161-7174.
51. Sadler R, Wu L, Forghani B, Renne R, Zhong W, Herndier B, Ganem D. 1999. A complex translational program generates multiple novel proteins from the latently expressed kaposin (K12) locus of Kaposi's sarcomaassociated herpesvirus. J. Virol. 73:5722-5730.
52. Santarelli R, Farina A, Granato M, Gonnella R, Raffa S, Leone L, Bei R, Modesti A, Frati L, Torrisi MR, Faggioni A. 2008. Identification and characterization of the product encoded by ORF69 of Kaposi's sarcomaassociated herpesvirus. J. Virol. 82:4562-4572.
53. Talbot SJ, Weiss RA, Kellam P, Boshoff C. 1999. Transcriptional analysis of human herpesvirus-8 open reading frames 71, 72, 73, K14, and 74 in a primary effusion lymphoma cell line. Virology 257:84-94.
54. Taylor JL, Bennett HN, Snyder BA, Moore PS, Chang Y. 2005. Transcriptional analysis of latent and inducible Kaposi's sarcoma-associated herpesvirus transcripts in the K4 to K7 region. J. Virol. 79:15099-15106.
55. Wang L, Pietrek M, Brinkmann MM, Havemeier A, Fischer I, Hillenbrand B, Dittrich-Breiholz O, Kracht M, Chanas S, Blackbourn DJ, Schulz TF. 2009. Identification and functional characterization of a spliced rhesus rhadinovirus gene with homology to the K15 gene of Kaposi's sarcoma-associated herpesvirus. J. Gen. Virol. 90:1190-1201.
56. Wu FY, Ahn JH, Alcendor DJ, Jang WJ, Xiao J, Hayward SD, Hayward GS. 2001. Origin-independent assembly of Kaposi's sarcoma-associated herpesvirus DNA replication compartments in transient cotransfection assays and association with the ORF-K8 protein and cellular PML. J. Virol. 75:1487-1506.
57. Zhu FX, Cusano T, Yuan Y. 1999. Identification of the immediate-early transcripts of Kaposi's sarcoma-associated herpesvirus. J. Virol. 73:5556-5567.
58. Li H, Komatsu T, Dezube BJ, Kaye KM. 2002. The Kaposi's sarcomaassociated herpesvirus K12 transcript from a primary effusion lymphoma contains complex repeat elements, is spliced, and initiates from a novel promoter. J. Virol. 76:11880-11888.
59. Pesole G, Mignone F, Gissi C, Grillo G, Licciulli F, Liuni S. 2001. Structural and functional features of eukaryotic mRNA untranslated regions. Gene 276:73-81.
60. Santhanam AN, Bindewald E, Rajasekhar VK, Larsson O, Sonenberg N, Colburn NH, Shapiro BA. 2009. Role of 3'UTRs in the translation of mRNAs regulated by oncogenic eIF4E-a computational inference. PLoS One 4:e4868. doi:10.1371/journal.pone.0004868.
61. Bartel DP. 2009. MicroRNAs:target recognition and regulatory functions. Cell 136:215-233.
62. St Johnston D. 2005. Moving messages:the intracellular localization of mRNAs. Nat. Rev. Mol. Cell Biol. 6:363-375.
63. Stubbs SH, Hunter OV, Hoover A, Conrad NK. 2012. Viral factors reveal a role for REF/Aly in nuclear RNA stability. Mol. Cell. Biol. 32: 1260-1270.
64. Meijer HA, Kong YW, Lu WT, Wilczynska A, Spriggs RV, Robinson SW, Godfrey JD, Willis AE, Bushell M. 2013. Translational repression and eIF4A2 activity are critical for microRNA-mediated gene regulation. Science 340:82-85.
65. Nicholson BL, Wu B, Chevtchenko I, White KA. 2010. Tombusvirus recruitment of host translational machinery via the 3' UTR. RNA 16: 1402-1419.
66. Stupina VA, Yuan X, Meskauskas A, Dinman JD, Simon AE. 2011. Ribosome binding to a 5' translational enhancer is altered in the presence of the 3' untranslated region in cap-independent translation of turnip crinkle virus. J. Virol. 85:4638-4653.
67. Conrad NK, Steitz JA. 2005. A Kaposi's sarcoma virus RNA element that increases the nuclear abundance of intronless transcripts. EMBO J. 24: 1831-1841.
68. Krek A, Grun D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC, Stoffel M, Rajewsky N. 2005. Combinatorial microRNA target predictions. Nat. Genet. 37: 495-500.
69. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J, Bartel DP, Linsley PS, Johnson JM. 2005. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433:769-773.
70. Ray D, Kazan H, Cook KB, Weirauch MT, Najafabadi HS, Li X, Gueroussov S, Albu M, Zheng H, Yang A, Na H, Irimia M, Matzat LH, Dale RK, Smith SA, Yarosh CA, Kelly SM, Nabet B, Mecenas D, Li W, Laishram RS, Qiao M, Lipshitz HD, Piano F, Corbett AH, Carstens RP, Frey BJ, Anderson RA, Lynch KW, Penalva LO, Lei EP, Fraser AG, Blencowe BJ, Morris QD, Hughes TR. 2013. A compendium of RNA-binding motifs for decoding gene regulation. Nature 499:172-177.
71. Qu X, Wen JD, Lancaster L, Noller HF, Bustamante C, Tinoco I, Jr. 2011. The ribosome uses two active mechanisms to unwind messenger RNA during translation. Nature 475:118-121.
72. Kudla G, Lipinski L, Caffin F, Helwak A, Zylicz M. 2006. High guanine and cytosine content increases mRNA levels in mammalian cells. PLoS Biol. 4:e180. doi:10.1371/journal.pbio.0040180.
73. Chandriani S, Ganem D. 2007. Host transcript accumulation during lytic KSHV infection reveals several classes of host responses. PLoS One 2:e811. doi:10.1371/journal.pone.0000811.
74. Glaunsinger B, Ganem D. 2004. Highly selective escape from KSHVmediated hostmRNAshutoff and its implications for viral pathogenesis. J. Exp. Med. 200:391-398.
75. Hutin S, Lee Y, Glaunsinger BA. 2013. An RNA element in human interleukin 6 confers escape from degradation by the gammaherpesvirus SOX protein. J. Virol. 87:4672-4682.
76. Glaunsinger B, Ganem D. 2004. Lytic KSHV infection inhibits host gene expression by accelerating global mRNA turnover. Mol. Cell 13:713-723.
77. Li X, Chen S, Feng J, Deng H, Sun R. 2010. Myc is required for the maintenance of Kaposi's sarcoma-associated herpesvirus latency. J. Virol. 84:8945-8948.
78. Bu W, Palmeri D, Krishnan R, Marin R, Aris VM, Soteropoulos P, Lukac DM. 2008. Identification of direct transcriptional targets of the Kaposi's sarcoma-associated herpesvirus Rta lytic switch protein by conditional nuclear localization. J. Virol. 82:10709-10723.
79. Sun R, Lin SF, Gradoville L, Yuan Y, Zhu F, Miller G. 1998. A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus. Proc. Natl. Acad. Sci. U.S.A. 95:10866-10871.
80. Xu Y, AuCoin DP, Huete AR, Cei SA, Hanson LJ, Pari GS. 2005. A Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 ORF50 deletion mutant is defective for reactivation of latent virus and DNA replication. J. Virol. 79:3479-3487.
81. Xi X, Persson LM, O'Brien MW, Mohr I, Wilson AC. 2012. Cooperation between viral interferon regulatory factor 4 and RTA to activate a subset of Kaposi's sarcoma-associated herpesvirus lytic promoters. J. Virol. 86: 1021-1033.
82. Tuxworth WJ, Jr, Saghir AN, Spruill LS, Menick DR, McDermott PJ. 2004. Regulation of protein synthesis by eIF4E phosphorylation in adult cardiocytes:the consequence of secondary structure in the 5'-untranslated region of mRNA. Biochem. J. 378:73-82.
83. Buxade M, Parra JL, Rousseau S, Shpiro N, Marquez R, Morrice N, Bain J, Espel E, Proud CG. 2005. The Mnks are novel components in the control of TNF alpha biosynthesis and phosphorylate and regulate hnRNP A1. Immunity 23:177-189.
84. Furic L, Rong L, Larsson O, Koumakpayi IH, Yoshida K, Brueschke A, Petroulakis E, Robichaud N, Pollak M, Gaboury LA, Pandolfi PP, Saad F, Sonenberg N. 2010. eIF4E phosphorylation promotes tumorigenesis and is associated with prostate cancer progression. Proc. Natl. Acad. Sci. U.S.A. 107:14134-14139.
85. Herdy B, Jaramillo M, Svitkin YV, Rosenfeld AB, Kobayashi M, Walsh D, Alain T, Sean P, Robichaud N, Topisirovic I, Furic L, Dowling RJ, Sylvestre A, Rong L, Colina R, Costa-Mattioli M, Fritz JH, Olivier M, Brown E, Mohr I, Sonenberg N. 2012. Translational control of the activation of transcription factor NF-kappaB and production of type I interferon by phosphorylation of the translation factor eIF4E. Nat. Immunol. 13:543-550.